Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Shareholders' Deficit (Unaudited)

v3.23.1
Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Previously Reported
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
Previously Reported
Redeemable Convertible Preferred Stock
Retroactive Application of Reverse Capitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Retroactive Application of Reverse Capitalization
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive Application of Reverse Capitalization
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Non-controlling Interest
Non-controlling Interest
Previously Reported
Beginning balance at Dec. 31, 2020 $ (27,091) $ (27,091)       $ 7   $ 7 $ 7,447 $ 7,454 $ (7) $ (58,084) $ (58,084) $ (204) $ (204) $ 23,743 $ 23,743
Beginning balance, Shares at Dec. 31, 2020           67,297,473 2,439,634 64,857,839                  
Beginning balance at Dec. 31, 2020     $ 8,000 $ 8,000                          
Beginning balance, Shares at Dec. 31, 2020     10,947,686 396,870 10,550,816                        
Net loss (138,982)                     (138,982)          
Other comprehensive income (loss), net of tax 168                         168      
Issuance of common stock in exchange for non-controlling interest, net of issuance costs (432)         $ 1     23,310             $ (23,743)  
Issuance of common stock in exchange for non-controlling interest, net of issuance costs, Shares           10,704,772                      
Issuance of warrants, net of issuance costs 66,060               66,060                
Share-based compensation 678               678                
Exercise of stock options 242               242                
Exercise of stock options, Shares           599,038                      
Ending balance at Dec. 31, 2021 (99,357)         $ 8     97,737     (197,066)   (36)      
Ending balance (ASU 2016-13) at Dec. 31, 2021 (122)                     (122)          
Ending balance, Shares at Dec. 31, 2021           78,601,283                      
Ending balance at Dec. 31, 2021 8,000   $ 8,000                            
Ending balance, Shares at Dec. 31, 2021     10,947,686                            
Net loss (163,980)                     (163,980)          
Other comprehensive income (loss), net of tax 195                         195      
Conversion of redeemable convertible preferred stock into common stock 8,000         $ 1     7,999                
Conversion of redeemable convertible preferred stock into common stock, Shares           10,947,686                      
Conversion of redeemable convertible preferred stock into common stock     $ (8,000)                            
Conversion of redeemable convertible preferred stock into common stock, Shares     (10,947,686)                            
Net settlement of liability-classified warrants into common stock 7,616               7,616                
Net settlement of liability-classified warrants into common stock, Shares           694,873                      
Net settlement of equity-classified warrants into common stock           $ 2     (2)                
Net settlement of equity-classified warrants into common stock, Shares           22,343,698                      
Issuance of common stock in connection with the Tailwind Two Merger and PIPE Investment, net of issuance costs 6,928         $ 2     6,926                
Issuance of common stock in connection with the Tailwind Two Merger and PIPE Investment, net of issuance costs, Shares           16,114,695                      
Issuance of common stock in connection with financing transactions, net of issuance costs 40,734         $ 1     40,733                
Issuance of common stock in connection with financing transactions, net of issuance costs, Shares           4,325,000                      
Reclassification of liability-classified warrants and derivatives to equity-classified 11,007               11,007                
Issuance of contingently issuable common stock 44,887               44,887                
Issuance of contingently issuable common stock, Shares           4,095,569                      
Issuance of common stock under the Committed Equity Facility 2,795               2,795                
Issuance of common stock under the Committed Equity Facility, shares           637,487                      
Share-based compensation 51,082               51,082                
Settlement of vested restricted stock units, net of net share settlements (1,515)               (1,515)                
Settlement of vested restricted stock units, net of net share settlements, Shares           4,404,201                      
Exercise of stock options $ 356               356                
Exercise of stock options, Shares 339,279         339,279                      
Other $ (47)               (47)                
Ending balance at Dec. 31, 2022 (91,421)         $ 14     $ 269,574     $ (361,168)   $ 159      
Ending balance, Shares at Dec. 31, 2022           142,503,771                      
Ending balance at Dec. 31, 2022                                
Ending balance, Shares at Dec. 31, 2022     0